Literature DB >> 8251178

51Cr-release assay adapted to a 96-well format sample reading.

G G Hillman1, N Roessler, R S Fulbright, J E Pontes, G P Haas.   

Abstract

The application of the Matrix 96, a direct beta counter, to monitor cell-mediated lympholysis assays (CML) was investigated. Until now, the gamma rays emitted from 51Cr, released in the supernatant of the sample following lysis of targets by effector cells, were read in gamma counters using individual tubes for each sample. The Matrix 96 has been designed to count 96 wells simultaneously for assays performed in 96-well microplates. Aliquots of supernatants were spotted on a 96-well disposable metal spotting plate and dried prior to reading in the Matrix 96. A tight correlation was observed between the counts obtained in the Matrix 96 and a gamma counter, which indicates that the detection of electron capture beta particles emitted from 51Cr was as accurate as reading gamma rays from the same isotope. Both methods confirmed the minimal level of cytotoxicity mediated by unstimulated lymphocytes and the high levels of nonspecific cytolytic activity mediated by lymphokine-activated killer (LAK) cells against several tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8251178

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  2 in total

1.  Comparison of benchtop microplate beta counters with the traditional gamma counting method for measurement of chromium-51 release in cytotoxic assays.

Authors:  Dora Wallace; Allan Hildesheim; Ligia A Pinto
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

2.  Effects of biomaterials for Lab-on-a-chip production on cell growth and expression of differentiated functions of leukemic cell lines.

Authors:  Federica Destro; Monica Borgatti; Bruno Iafelice; Riccardo Gavioli; Tanja Braun; Jörg Bauer; Lars Böttcher; Erik Jung; Massimo Bocchi; Roberto Guerrieri; Roberto Gambari
Journal:  J Mater Sci Mater Med       Date:  2010-07-13       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.